MG217 Psoriasis

Manufacturer: Wisconsin Pharmacal Company
Effective date: 2018-12-10
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:57:36

Label at a glance#

ProductMG217 Psoriasis Therapeutic Scalp Treatment

Active ingredientCOAL TAR

Label structure8 sections

Dosage and administration

shake well before using. wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly. for best results, use at least twice a week or as directed by a physician.

Contacts and useful links#

PhoneLabel contact1-800-635-3696

Websitewww.p65warnings.ca.gov

www.P65Warnings.ca.gov

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient

Coal Tar 3%

(from Coal Tar Topical Solution, USP 20%)

Purpose

OTC - PURPOSE SECTION

Psoriasis, Seborrheic Dermatitis, Dandruff Treatment

INDICATIONS & USAGE SECTION

Uses For the temporary relief of these symptoms associated with psoriasis, seborrheic dermatitis or dandruff

itching
scaling
flaking
redness
irritation ofthe scalp.

Helps prevent recurrence.

WARNINGS SECTION

Warnings

For external use only.

Ask doctor before use

OTC - ASK DOCTOR SECTION

if condition covers a large area of the body.

When using this product

OTC - WHEN USING SECTION

avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
use caution in exposing skin to sunlight. It may increase your tendency to sunburn for up to 24 hours after application.
do not use with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed by a physician.
do not use for prolonged periods without consulting a physician.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens.
condition does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

OTHER SAFETY INFORMATION

WARNING This product can gose you to chemicals including Coal Tar, which is known to the State of California to cause cancer.
For more information go to www.P65Warnings.ca.gov

Directions

DOSAGE & ADMINISTRATION SECTION

shake well before using.
wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly.
for best results, use at least twice a week or as directed by a physician.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Deionized water, Sodium Alkyl Ether Sulfate, Cocamidopropyl Betaine, Lauramidopropyl Hydroxysultaine, Palmitic Betaine, Guar Hydroxypropyltrimonium Chloride, Hydrolyzed Collagen, Phenoxyethanol, Methyl Paraben, n-Butyl Paraben, Ethyl Paraben, Isobutyl Paraben, Propyl Paraben, Fragrance FD and C No. 1

Questions?

OTC - QUESTIONS SECTION

1-800-635-3696

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cartonlabel'

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
205100	coal tar 3 % Medicated Shampoo	PSN	2
205100	coal tar 30 MG/ML Medicated Shampoo	SCD	2
205100	coal tar 3 % Medicated Shampoo	SY	2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68093-5206-1	MG217 PsoriasisTherapeutic Scalp Treatment	120 g in 1 BOTTLE	SHAMPOO	120		2
68093-5206-1	MG217 PsoriasisTherapeutic Scalp Treatment	1 in 1 CARTON	SHAMPOO	1		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68093-5206	MG217 PSORIASIS THERAPEUTIC SCALP TREATMENT (COAL TAR) SHAMPOO [WISCONSIN PHARMACAL COMPANY]	2	Current NDC, Legacy NDC, 2 package rows	20181213_6d3f4685-eb47-445e-86fb-3601d2c110e7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Coal Tar	ACTIVE INGREDIENT	R533ESO2EC	1
COAL TAR	ACTIVE MOIETY	R533ESO2EC	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	1
CETYL BETAINE	INACTIVE INGREDIENT	E945X08YA9	1
COCAMIDOPROPYL BETAINE	INACTIVE INGREDIENT	5OCF3O11KX	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	1
GUAR GUM	INACTIVE INGREDIENT	E89I1637KE	1
ISOBUTYLPARABEN	INACTIVE INGREDIENT	0QQJ25X58G	1
LAURAMIDOPROPYL HYDROXYSULTAINE	INACTIVE INGREDIENT	VPE363894V	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
PORK COLLAGEN	INACTIVE INGREDIENT	I8442U2G7J	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SODIUM LAURETH SULFATE	INACTIVE INGREDIENT	BPV390UAP0	1
Water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

MG217 Psoriasis Therapeutic Scalp Treatment
Coal Tar
WATER
SODIUM LAURETH SULFATE
COCAMIDOPROPYL BETAINE
LAURAMIDOPROPYL HYDROXYSULTAINE
PHENOXYETHANOL
CETYL BETAINE
GUAR GUM
PORK COLLAGEN
METHYLPARABEN
BUTYLPARABEN
ISOBUTYLPARABEN
PROPYLPARABEN
FD&C BLUE NO. 1
ETHYLPARABEN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68093-5206	68093-5206-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
SODIUM LAURETH SULFATE	BPV390UAP0	IACT
COCAMIDOPROPYL BETAINE	5OCF3O11KX	IACT
LAURAMIDOPROPYL HYDROXYSULTAINE	VPE363894V	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
CETYL BETAINE	E945X08YA9	IACT
GUAR GUM	E89I1637KE	IACT
PORK COLLAGEN	I8442U2G7J	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
BUTYLPARABEN	3QPI1U3FV8	IACT
ISOBUTYLPARABEN	0QQJ25X58G	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
ETHYLPARABEN	14255EXE39	IACT
COAL TAR	R533ESO2EC	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 38 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SHAMPOO / TOPICAL	0.75 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SUSPENSION / ORAL		8 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL, FOAM / TOPICAL		72 mg	Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii+route 12 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	OINTMENT / TOPICAL	0.18 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	LOTION / TOPICAL		4 mg	Exact identifier — unii+route 8 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	LIQUID / TOPICAL	0.02 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM / TOPICAL		57 mg	Exact identifier — unii+route 12 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	CREAM / TOPICAL	0.4 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	LIQUID / TOPICAL	0.02 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
SODIUM LAURETH SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	SHAMPOO / TOPICAL		3192 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SHAMPOO / TOPICAL	0.03 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM / TOPICAL		57 mg	Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL, FOAM / TOPICAL		72 mg	Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	GRANULE, FOR SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
GUAR GUM	GUAR GUM	E89I1637KE	LOTION / TOPICAL	NA		Exact identifier — unii+route 2 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	GRANULE, FOR SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	OINTMENT / TOPICAL	0.18 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
SODIUM LAURETH SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	SHAMPOO / TOPICAL		3192 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SUSPENSION / ORAL		8 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SHAMPOO / TOPICAL	0.75 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	LOTION / TOPICAL		4 mg	Exact identifier — unii+route 8 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	CREAM / TOPICAL	0.4 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SHAMPOO / TOPICAL	0.03 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
GUAR GUM	GUAR GUM	E89I1637KE	LOTION / TOPICAL	NA		Exact identifier — unii+route 2 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 8 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MG217 Psoriasis Therapeutic Scalp Treatment	COAL TAR	Wisconsin Pharmacal Company	6d3f4685-eb47-445e-86fb-3601d2c110e7	2018-12-10	Warnings	Exact identifier ndc (package): 68093-5206-1 ndc (product): 68093-5206 ndc11 (package): 68093520601 spl id: 7caf9ab6-f870-25f4-e053-2a91aa0aa16d spl set id: 6d3f4685-eb47-445e-86fb-3601d2c110e7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.